HUP0104122A3 - N-arylsulfonyl amino acid omega amides, process for preparation of the compounds and pharmaceutical compositions containing them - Google Patents
N-arylsulfonyl amino acid omega amides, process for preparation of the compounds and pharmaceutical compositions containing themInfo
- Publication number
- HUP0104122A3 HUP0104122A3 HU0104122A HUP0104122A HUP0104122A3 HU P0104122 A3 HUP0104122 A3 HU P0104122A3 HU 0104122 A HU0104122 A HU 0104122A HU P0104122 A HUP0104122 A HU P0104122A HU P0104122 A3 HUP0104122 A3 HU P0104122A3
- Authority
- HU
- Hungary
- Prior art keywords
- amides
- compounds
- preparation
- amino acid
- pharmaceutical compositions
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19851184A DE19851184A1 (de) | 1998-11-06 | 1998-11-06 | N-Arylsulfonyl-aminosäure-omega-amide |
| PCT/EP1999/007979 WO2000027808A1 (de) | 1998-11-06 | 1999-10-21 | N-arylsulfonyl-aminosäure-omega-amide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104122A2 HUP0104122A2 (hu) | 2002-03-28 |
| HUP0104122A3 true HUP0104122A3 (en) | 2002-04-29 |
Family
ID=7886902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104122A HUP0104122A3 (en) | 1998-11-06 | 1999-10-21 | N-arylsulfonyl amino acid omega amides, process for preparation of the compounds and pharmaceutical compositions containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6201130B1 (hu) |
| EP (1) | EP1124797B1 (hu) |
| JP (1) | JP4348014B2 (hu) |
| KR (1) | KR100655632B1 (hu) |
| CN (1) | CN1206213C (hu) |
| AR (1) | AR021086A1 (hu) |
| AT (1) | ATE260889T1 (hu) |
| AU (1) | AU757602B2 (hu) |
| BR (1) | BR9915729A (hu) |
| CA (1) | CA2350031C (hu) |
| CZ (1) | CZ302291B6 (hu) |
| DE (2) | DE19851184A1 (hu) |
| DK (1) | DK1124797T3 (hu) |
| ES (1) | ES2213405T3 (hu) |
| HK (1) | HK1041686B (hu) |
| HU (1) | HUP0104122A3 (hu) |
| ID (1) | ID28810A (hu) |
| PL (1) | PL198827B1 (hu) |
| PT (1) | PT1124797E (hu) |
| RU (1) | RU2228330C2 (hu) |
| TR (1) | TR200101245T2 (hu) |
| WO (1) | WO2000027808A1 (hu) |
| ZA (1) | ZA200103485B (hu) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
| PA8591801A1 (es) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | Inhibidores benzamidicos del receptor p2x7. |
| US7071223B1 (en) * | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
| BRPI0409428A (pt) * | 2003-04-15 | 2006-04-18 | Warner Lambert Co | derivados de prolina bicìclicos [c]-fundidos e a sua utilização para tratar estados artrìticos |
| DE602004005033T2 (de) * | 2003-05-12 | 2007-08-09 | Pfizer Products Inc., Groton | Benzamidinhibitoren des p2x7-rezeptors |
| AU2005258911A1 (en) * | 2004-06-29 | 2006-01-12 | Pfizer Products Inc. | Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3H`1,2,4!triazin-2-YL!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| EP1763353A1 (en) * | 2004-06-29 | 2007-03-21 | Warner-Lambert Company LLC | COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR |
| BRPI0512651A (pt) * | 2004-06-29 | 2008-03-25 | Pfizer Prod Inc | método para a preparação de derivados de 5-4-(2-hidroxietil)-3,5-dioxo-4,5 dihidro-3h-1,2,4-trizin-2-ila com atividade inibidora de p2x7 por reaçaõ do derivado não substituìdo na posição 4 da trizina com um oxirano na presença de um ácido de lewis |
| US7576222B2 (en) | 2004-12-28 | 2009-08-18 | Wyeth | Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase |
| AR054631A1 (es) | 2005-07-11 | 2007-07-04 | Wyeth Corp | DERIVADOS DE L-ALFA-GLUTAMINA COMO INHIBIDORES DE GLUTAMATO AGRECANASA, INTERMEDIARIOS Y MÉTODOS DE SíNTESIS DE LOS MISMOS Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN. |
| TW200740729A (en) | 2005-10-13 | 2007-11-01 | Wyeth Corp | Methods for preparing glutamic acid derivatives |
| WO2012004743A1 (en) | 2010-07-09 | 2012-01-12 | Pfizer Limited | Benzenesulfonamides useful as sodium channel inhibitors |
| CN104955806B (zh) * | 2013-02-06 | 2018-09-14 | 默克专利股份公司 | 用于治疗骨关节炎的作为聚蛋白聚糖酶抑制剂的取代羧酸衍生物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1063026A1 (ru) * | 1982-05-19 | 1990-12-07 | Институт биохимии АН ЛитССР | N @ -Бензолсульфонильные производные трес-DL-фенилсерина, обладающие противовоспалительной активностью |
| JP2764262B2 (ja) | 1987-08-28 | 1998-06-11 | 持田製薬株式会社 | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 |
| TW201303B (hu) | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
| US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| GB2303850B (en) | 1994-06-22 | 1998-06-10 | British Biotech Pharm | Metalloproteinase inhibitors |
| US5863949A (en) * | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| AU6482396A (en) * | 1995-06-28 | 1997-01-30 | E.I. Du Pont De Nemours And Company | Fluoropolymer nanocomposites |
| KR980009238A (ko) | 1995-07-28 | 1998-04-30 | 우에노 도시오 | 설포닐아미노산 유도체 |
| SK282863B6 (sk) * | 1996-05-17 | 2002-12-03 | Warner-Lambert Company | Bifenylsulfonamidy, ich použitie a farmaceutické prostriedky na ich báze |
| DE19719621A1 (de) * | 1997-05-09 | 1998-11-12 | Hoechst Ag | Sulfonylaminocarbonsäuren |
-
1998
- 1998-11-06 DE DE19851184A patent/DE19851184A1/de not_active Withdrawn
-
1999
- 1999-10-21 PT PT99971799T patent/PT1124797E/pt unknown
- 1999-10-21 ES ES99971799T patent/ES2213405T3/es not_active Expired - Lifetime
- 1999-10-21 EP EP99971799A patent/EP1124797B1/de not_active Expired - Lifetime
- 1999-10-21 AT AT99971799T patent/ATE260889T1/de active
- 1999-10-21 AU AU11530/00A patent/AU757602B2/en not_active Ceased
- 1999-10-21 ID IDW00200100995A patent/ID28810A/id unknown
- 1999-10-21 WO PCT/EP1999/007979 patent/WO2000027808A1/de active IP Right Grant
- 1999-10-21 PL PL347574A patent/PL198827B1/pl not_active IP Right Cessation
- 1999-10-21 JP JP2000580988A patent/JP4348014B2/ja not_active Expired - Fee Related
- 1999-10-21 DK DK99971799T patent/DK1124797T3/da active
- 1999-10-21 HU HU0104122A patent/HUP0104122A3/hu unknown
- 1999-10-21 CZ CZ20011506A patent/CZ302291B6/cs not_active IP Right Cessation
- 1999-10-21 BR BR9915729-2A patent/BR9915729A/pt not_active Application Discontinuation
- 1999-10-21 TR TR2001/01245T patent/TR200101245T2/xx unknown
- 1999-10-21 KR KR1020017005590A patent/KR100655632B1/ko not_active IP Right Cessation
- 1999-10-21 CN CNB998129321A patent/CN1206213C/zh not_active Expired - Fee Related
- 1999-10-21 RU RU2001115706/04A patent/RU2228330C2/ru not_active IP Right Cessation
- 1999-10-21 DE DE59908769T patent/DE59908769D1/de not_active Expired - Lifetime
- 1999-10-21 CA CA2350031A patent/CA2350031C/en not_active Expired - Fee Related
- 1999-11-04 AR ARP990105584A patent/AR021086A1/es active IP Right Grant
- 1999-11-05 US US09/434,107 patent/US6201130B1/en not_active Expired - Lifetime
-
2000
- 2000-12-28 US US09/749,034 patent/US6335333B1/en not_active Expired - Lifetime
-
2001
- 2001-04-30 ZA ZA200103485A patent/ZA200103485B/en unknown
-
2002
- 2002-05-04 HK HK02103391.7A patent/HK1041686B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0104122A2 (hu) | 2002-03-28 |
| CZ302291B6 (cs) | 2011-02-09 |
| US6201130B1 (en) | 2001-03-13 |
| PT1124797E (pt) | 2004-07-30 |
| DK1124797T3 (da) | 2004-07-05 |
| DE19851184A1 (de) | 2000-05-11 |
| US6335333B1 (en) | 2002-01-01 |
| CZ20011506A3 (cs) | 2001-08-15 |
| WO2000027808A1 (de) | 2000-05-18 |
| AR021086A1 (es) | 2002-06-12 |
| EP1124797B1 (de) | 2004-03-03 |
| BR9915729A (pt) | 2001-10-23 |
| AU1153000A (en) | 2000-05-29 |
| HK1041686B (zh) | 2005-09-23 |
| CA2350031C (en) | 2010-01-26 |
| CN1206213C (zh) | 2005-06-15 |
| CN1332724A (zh) | 2002-01-23 |
| EP1124797A1 (de) | 2001-08-22 |
| JP2002529447A (ja) | 2002-09-10 |
| ES2213405T3 (es) | 2004-08-16 |
| PL347574A1 (en) | 2002-04-08 |
| ZA200103485B (en) | 2001-12-04 |
| CA2350031A1 (en) | 2000-05-18 |
| DE59908769D1 (de) | 2004-04-08 |
| HK1041686A1 (en) | 2002-07-19 |
| AU757602B2 (en) | 2003-02-27 |
| RU2228330C2 (ru) | 2004-05-10 |
| JP4348014B2 (ja) | 2009-10-21 |
| ATE260889T1 (de) | 2004-03-15 |
| KR20010080385A (ko) | 2001-08-22 |
| PL198827B1 (pl) | 2008-07-31 |
| KR100655632B1 (ko) | 2006-12-12 |
| TR200101245T2 (tr) | 2001-10-22 |
| ID28810A (id) | 2001-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL113625A0 (en) | Amino acid derivatives processes for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0100950A3 (en) | Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| IL115685A (en) | Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof | |
| HUP9801045A3 (en) | Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation | |
| HUP9801044A3 (en) | Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP9800813A3 (en) | Lactam-containing hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| HUP0004400A3 (en) | Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
| HUP9602507A3 (en) | Cyclic peptides, adhesion inhibitor pharmaceutical compositions comprising the compounds, process for the preparation of the compounds and the pharmaceutical compositions and the use of the compounds | |
| HUP0101281A3 (en) | Diphenyl-piperidine butanamides as glycine transport inhibitors, process for producing them, use of them for producing medicaments and the pharmaceutical compositions containing them | |
| HUP0000214A3 (en) | Alpha-substituted benzenesulphonamido hydroxamic acids, process for their preparation and pharmaceutical compositions containing them | |
| HUP0100601A3 (en) | Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof | |
| HUP0105108A3 (en) | Amide compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0002404A3 (en) | Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use | |
| HUP9903336A3 (en) | Substituted sulfonic acid n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds and pharmaceutical compositions containing the same | |
| IL138969A0 (en) | Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT71106A (en) | Propenoic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
| HUP0104122A3 (en) | N-arylsulfonyl amino acid omega amides, process for preparation of the compounds and pharmaceutical compositions containing them | |
| HUP9802517A3 (en) | Phosphonic acid-substituted benzazepinon-n-acetic acid derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0100488A3 (en) | Thienopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
| IL137494A0 (en) | Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0003053A3 (en) | Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202934A3 (en) | Arylsulfonamido-substituted hydroxamic acid derivatives, process for their preparation, pharmaceutical compositions containing them and use thereof | |
| HUP0002724A3 (en) | Clasto-lactacystin betha-lactone, analogs and intermediates thereof, process for their preparation and pharmaceutical compositions containing them | |
| HUP0100854A3 (en) | Cholenic acid amides, process for their preparation and pharmaceutical compositions thereof | |
| ZA966154B (en) | Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |